Triple-negative breast cancer: promising prognostic biomarkers currently in development

MLA

Maryam B. Lustberg, et al. “Triple-Negative Breast Cancer: Promising Prognostic Biomarkers Currently in Development.” Expert Review of Anticancer Therapy, vol. 21, no. 2, Jan. 2021, pp. 135–48. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....41abdd0c5e5ecbdb7127ca0f6511a223&authtype=sso&custid=ns315887.

APA

Maryam B. Lustberg, Jasmine Sukumar, Nicole Williams, Dionisia Quiroga, & Kelly Gast. (2021). Triple-negative breast cancer: promising prognostic biomarkers currently in development. Expert Review of Anticancer Therapy, 21(2), 135–148.

Chicago

Maryam B. Lustberg, Jasmine Sukumar, Nicole Williams, Dionisia Quiroga, and Kelly Gast. 2021. “Triple-Negative Breast Cancer: Promising Prognostic Biomarkers Currently in Development.” Expert Review of Anticancer Therapy 21 (2): 135–48. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....41abdd0c5e5ecbdb7127ca0f6511a223&authtype=sso&custid=ns315887.